NGS continually delivers breakthroughs in genomics, and to do so, it relies on the crucial step of sample preparation. Complex and expensive workflows are significant challenges. At Revvity, we are ...

Current antiretroviral therapies (ART), when taken daily, suppress viral loads of human immunodeficiency virus 1 infections (HIV-1) such that ongoing viral transmission is halted 1,2,3. A variety of ...

Fred Sanger was awarded the Nobel Prize in Chemistry in 1980 for the discovery of dideoxynucleotide sequencing of DNA, merely 3 years after a description of the technique was published 1. In the ...

Next-generation sequencing (NGS) has revolutionized genomics, empowering scientists with a powerful tool to sequence millions of DNA fragments at once. This transformative technology has increased the ...

This eBook explores next-generation sequencing (NGS) methods and their applications in neurological and cancer research, with key content from BioTechniques’ digital hub and Taylor & Francis journals, ...

The webinar series titled "The Basics of Next Generation Sequencing and its Application in Precision Oncology" aims to provide a comprehensive understanding of the fundamentals and practical ...

Even the most straightforward next-generation sequencing (NGS) experiments can be expensive and time-consuming. Thus, it’s a good idea to test your workflow on a few samples to make sure you’ll get ...

Roche debuts Axelios, a gene sequencer targeting academic and research facilities, to compete with Illumina's dominance in ...

The launch was supported by collaborations with institutions such as the Hartwig Medical Foundation and Broad Clinical Labs.

Human Epidermal Growth Factor Receptor 2 Quantification Using Computational Pathology to Identify Novel Biomarkers for Trastuzumab Deruxtecan–Treated Human Epidermal Growth Factor Receptor 2–Positive ...

Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic non-small cell lung cancer. Utilizing TP53 mutation status and initial disease burden at presentation to ...